small-molecule protein degraders

Pathway to discovery in rare disease

Sanofi researchers are investigating a metabolic hub that plays a key role in three classes of rare disease


The Fight against COVID-19

As the pandemic continues, Sanofi is at the forefront of vaccine development, while carrying on the daily business of making and delivering medicines for patients

woman writing on a transparent wall

Giving Voice to All Breast Cancer Patients

"People tell me, you can’t save the world and I say, yes, I can. I do it every day, one person at a time" -Maimah Karmo, founder of the Tigerlily Foundation

Third quarter 2020 results

Third Quarter Results 2020

Sanofi’s financial results will be published on October 29, providing a look at its business performance and the execution of its strategy

  • Camera
    Press releases
    2020-10-28MMMM DD YYYY
    Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccine

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies